MedTrace Logo

Daily and Weekly Iron Supplementation in Infants

NCT06318858 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-04-05

No results posted yet for this study

Summary

This study aims to compare the efficacy of daily iron supplementation and weekly iron supplementation in infants aged 6-12 months on the prevalence of anemia, hemoglobin level, and serum ferritin levels. Infants will be enrolled at 6 months and will be randomly assigned to receive either daily or weekly iron supplementation for the first 3 months and will be followed by weekly iron supplementation for another 3 months.

Conditions

  • Anemia
  • Iron Status
  • Infants
  • Iron

Interventions

DIETARY_SUPPLEMENT

Iron supplement

Group 1: 12.5 mg daily iron syrup supplementation from 6-9 months old

Sponsors & Collaborators

  • Suranaree University of Technology

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Tippawan Pongcharoen, PhD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-08-14
Completion
2024-10-14

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06318858 on ClinicalTrials.gov